Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome
Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of...
Ausführliche Beschreibung
Autor*in: |
Kong, Jee Hyun [verfasserIn] Lee, Jeeyun [verfasserIn] Yi, Chin-A [verfasserIn] Park, Se Hoon [verfasserIn] Park, Joon Oh [verfasserIn] Park, Young Suk [verfasserIn] Lim, Ho Yeong [verfasserIn] Park, Keon Woo [verfasserIn] Kang, Won Ki [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2011 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: Gastric Cancer - Springer-Verlag, 2002, 15(2011), 3 vom: 29. Okt., Seite 292-298 |
---|---|
Übergeordnetes Werk: |
volume:15 ; year:2011 ; number:3 ; day:29 ; month:10 ; pages:292-298 |
Links: |
---|
DOI / URN: |
10.1007/s10120-011-0104-7 |
---|
Katalog-ID: |
SPR009317791 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR009317791 | ||
003 | DE-627 | ||
005 | 20201124064103.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201005s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10120-011-0104-7 |2 doi | |
035 | |a (DE-627)SPR009317791 | ||
035 | |a (SPR)s10120-011-0104-7-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kong, Jee Hyun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. | ||
650 | 4 | |a Pulmonary metastasis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Gastric cancer |7 (dpeaa)DE-He213 | |
650 | 4 | |a Hematogenous metastasis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Lymphangitic metastasis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Pleural metastasis |7 (dpeaa)DE-He213 | |
700 | 1 | |a Lee, Jeeyun |e verfasserin |4 aut | |
700 | 1 | |a Yi, Chin-A |e verfasserin |4 aut | |
700 | 1 | |a Park, Se Hoon |e verfasserin |4 aut | |
700 | 1 | |a Park, Joon Oh |e verfasserin |4 aut | |
700 | 1 | |a Park, Young Suk |e verfasserin |4 aut | |
700 | 1 | |a Lim, Ho Yeong |e verfasserin |4 aut | |
700 | 1 | |a Park, Keon Woo |e verfasserin |4 aut | |
700 | 1 | |a Kang, Won Ki |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gastric Cancer |d Springer-Verlag, 2002 |g 15(2011), 3 vom: 29. Okt., Seite 292-298 |w (DE-627)SPR009286586 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2011 |g number:3 |g day:29 |g month:10 |g pages:292-298 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10120-011-0104-7 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 15 |j 2011 |e 3 |b 29 |c 10 |h 292-298 |
author_variant |
j h k jh jhk j l jl c a y cay s h p sh shp j o p jo jop y s p ys ysp h y l hy hyl k w p kw kwp w k k wk wkk |
---|---|
matchkey_str |
kongjeehyunleejeeyunyichinaparksehoonpar:2011----:ugeatssneattcaticneptenfugeats |
hierarchy_sort_str |
2011 |
publishDate |
2011 |
allfields |
10.1007/s10120-011-0104-7 doi (DE-627)SPR009317791 (SPR)s10120-011-0104-7-e DE-627 ger DE-627 rakwb eng Kong, Jee Hyun verfasserin aut Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. Pulmonary metastasis (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Hematogenous metastasis (dpeaa)DE-He213 Lymphangitic metastasis (dpeaa)DE-He213 Pleural metastasis (dpeaa)DE-He213 Lee, Jeeyun verfasserin aut Yi, Chin-A verfasserin aut Park, Se Hoon verfasserin aut Park, Joon Oh verfasserin aut Park, Young Suk verfasserin aut Lim, Ho Yeong verfasserin aut Park, Keon Woo verfasserin aut Kang, Won Ki verfasserin aut Enthalten in Gastric Cancer Springer-Verlag, 2002 15(2011), 3 vom: 29. Okt., Seite 292-298 (DE-627)SPR009286586 nnns volume:15 year:2011 number:3 day:29 month:10 pages:292-298 https://dx.doi.org/10.1007/s10120-011-0104-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 15 2011 3 29 10 292-298 |
spelling |
10.1007/s10120-011-0104-7 doi (DE-627)SPR009317791 (SPR)s10120-011-0104-7-e DE-627 ger DE-627 rakwb eng Kong, Jee Hyun verfasserin aut Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. Pulmonary metastasis (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Hematogenous metastasis (dpeaa)DE-He213 Lymphangitic metastasis (dpeaa)DE-He213 Pleural metastasis (dpeaa)DE-He213 Lee, Jeeyun verfasserin aut Yi, Chin-A verfasserin aut Park, Se Hoon verfasserin aut Park, Joon Oh verfasserin aut Park, Young Suk verfasserin aut Lim, Ho Yeong verfasserin aut Park, Keon Woo verfasserin aut Kang, Won Ki verfasserin aut Enthalten in Gastric Cancer Springer-Verlag, 2002 15(2011), 3 vom: 29. Okt., Seite 292-298 (DE-627)SPR009286586 nnns volume:15 year:2011 number:3 day:29 month:10 pages:292-298 https://dx.doi.org/10.1007/s10120-011-0104-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 15 2011 3 29 10 292-298 |
allfields_unstemmed |
10.1007/s10120-011-0104-7 doi (DE-627)SPR009317791 (SPR)s10120-011-0104-7-e DE-627 ger DE-627 rakwb eng Kong, Jee Hyun verfasserin aut Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. Pulmonary metastasis (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Hematogenous metastasis (dpeaa)DE-He213 Lymphangitic metastasis (dpeaa)DE-He213 Pleural metastasis (dpeaa)DE-He213 Lee, Jeeyun verfasserin aut Yi, Chin-A verfasserin aut Park, Se Hoon verfasserin aut Park, Joon Oh verfasserin aut Park, Young Suk verfasserin aut Lim, Ho Yeong verfasserin aut Park, Keon Woo verfasserin aut Kang, Won Ki verfasserin aut Enthalten in Gastric Cancer Springer-Verlag, 2002 15(2011), 3 vom: 29. Okt., Seite 292-298 (DE-627)SPR009286586 nnns volume:15 year:2011 number:3 day:29 month:10 pages:292-298 https://dx.doi.org/10.1007/s10120-011-0104-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 15 2011 3 29 10 292-298 |
allfieldsGer |
10.1007/s10120-011-0104-7 doi (DE-627)SPR009317791 (SPR)s10120-011-0104-7-e DE-627 ger DE-627 rakwb eng Kong, Jee Hyun verfasserin aut Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. Pulmonary metastasis (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Hematogenous metastasis (dpeaa)DE-He213 Lymphangitic metastasis (dpeaa)DE-He213 Pleural metastasis (dpeaa)DE-He213 Lee, Jeeyun verfasserin aut Yi, Chin-A verfasserin aut Park, Se Hoon verfasserin aut Park, Joon Oh verfasserin aut Park, Young Suk verfasserin aut Lim, Ho Yeong verfasserin aut Park, Keon Woo verfasserin aut Kang, Won Ki verfasserin aut Enthalten in Gastric Cancer Springer-Verlag, 2002 15(2011), 3 vom: 29. Okt., Seite 292-298 (DE-627)SPR009286586 nnns volume:15 year:2011 number:3 day:29 month:10 pages:292-298 https://dx.doi.org/10.1007/s10120-011-0104-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 15 2011 3 29 10 292-298 |
allfieldsSound |
10.1007/s10120-011-0104-7 doi (DE-627)SPR009317791 (SPR)s10120-011-0104-7-e DE-627 ger DE-627 rakwb eng Kong, Jee Hyun verfasserin aut Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. Pulmonary metastasis (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Hematogenous metastasis (dpeaa)DE-He213 Lymphangitic metastasis (dpeaa)DE-He213 Pleural metastasis (dpeaa)DE-He213 Lee, Jeeyun verfasserin aut Yi, Chin-A verfasserin aut Park, Se Hoon verfasserin aut Park, Joon Oh verfasserin aut Park, Young Suk verfasserin aut Lim, Ho Yeong verfasserin aut Park, Keon Woo verfasserin aut Kang, Won Ki verfasserin aut Enthalten in Gastric Cancer Springer-Verlag, 2002 15(2011), 3 vom: 29. Okt., Seite 292-298 (DE-627)SPR009286586 nnns volume:15 year:2011 number:3 day:29 month:10 pages:292-298 https://dx.doi.org/10.1007/s10120-011-0104-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 15 2011 3 29 10 292-298 |
language |
English |
source |
Enthalten in Gastric Cancer 15(2011), 3 vom: 29. Okt., Seite 292-298 volume:15 year:2011 number:3 day:29 month:10 pages:292-298 |
sourceStr |
Enthalten in Gastric Cancer 15(2011), 3 vom: 29. Okt., Seite 292-298 volume:15 year:2011 number:3 day:29 month:10 pages:292-298 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Pulmonary metastasis Gastric cancer Hematogenous metastasis Lymphangitic metastasis Pleural metastasis |
isfreeaccess_bool |
false |
container_title |
Gastric Cancer |
authorswithroles_txt_mv |
Kong, Jee Hyun @@aut@@ Lee, Jeeyun @@aut@@ Yi, Chin-A @@aut@@ Park, Se Hoon @@aut@@ Park, Joon Oh @@aut@@ Park, Young Suk @@aut@@ Lim, Ho Yeong @@aut@@ Park, Keon Woo @@aut@@ Kang, Won Ki @@aut@@ |
publishDateDaySort_date |
2011-10-29T00:00:00Z |
hierarchy_top_id |
SPR009286586 |
id |
SPR009317791 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR009317791</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20201124064103.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201005s2011 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s10120-011-0104-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR009317791</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s10120-011-0104-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kong, Jee Hyun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pulmonary metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastric cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematogenous metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphangitic metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pleural metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Jeeyun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yi, Chin-A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Se Hoon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Joon Oh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Young Suk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lim, Ho Yeong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Keon Woo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, Won Ki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Gastric Cancer</subfield><subfield code="d">Springer-Verlag, 2002</subfield><subfield code="g">15(2011), 3 vom: 29. Okt., Seite 292-298</subfield><subfield code="w">(DE-627)SPR009286586</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:3</subfield><subfield code="g">day:29</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:292-298</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s10120-011-0104-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2011</subfield><subfield code="e">3</subfield><subfield code="b">29</subfield><subfield code="c">10</subfield><subfield code="h">292-298</subfield></datafield></record></collection>
|
author |
Kong, Jee Hyun |
spellingShingle |
Kong, Jee Hyun misc Pulmonary metastasis misc Gastric cancer misc Hematogenous metastasis misc Lymphangitic metastasis misc Pleural metastasis Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
authorStr |
Kong, Jee Hyun |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR009286586 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome Pulmonary metastasis (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Hematogenous metastasis (dpeaa)DE-He213 Lymphangitic metastasis (dpeaa)DE-He213 Pleural metastasis (dpeaa)DE-He213 |
topic |
misc Pulmonary metastasis misc Gastric cancer misc Hematogenous metastasis misc Lymphangitic metastasis misc Pleural metastasis |
topic_unstemmed |
misc Pulmonary metastasis misc Gastric cancer misc Hematogenous metastasis misc Lymphangitic metastasis misc Pleural metastasis |
topic_browse |
misc Pulmonary metastasis misc Gastric cancer misc Hematogenous metastasis misc Lymphangitic metastasis misc Pleural metastasis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Gastric Cancer |
hierarchy_parent_id |
SPR009286586 |
hierarchy_top_title |
Gastric Cancer |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)SPR009286586 |
title |
Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
ctrlnum |
(DE-627)SPR009317791 (SPR)s10120-011-0104-7-e |
title_full |
Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
author_sort |
Kong, Jee Hyun |
journal |
Gastric Cancer |
journalStr |
Gastric Cancer |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
2011 |
contenttype_str_mv |
txt |
container_start_page |
292 |
author_browse |
Kong, Jee Hyun Lee, Jeeyun Yi, Chin-A Park, Se Hoon Park, Joon Oh Park, Young Suk Lim, Ho Yeong Park, Keon Woo Kang, Won Ki |
container_volume |
15 |
format_se |
Elektronische Aufsätze |
author-letter |
Kong, Jee Hyun |
doi_str_mv |
10.1007/s10120-011-0104-7 |
author2-role |
verfasserin |
title_sort |
lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
title_auth |
Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
abstract |
Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. |
abstractGer |
Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. |
abstract_unstemmed |
Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER |
container_issue |
3 |
title_short |
Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome |
url |
https://dx.doi.org/10.1007/s10120-011-0104-7 |
remote_bool |
true |
author2 |
Lee, Jeeyun Yi, Chin-A Park, Se Hoon Park, Joon Oh Park, Young Suk Lim, Ho Yeong Park, Keon Woo Kang, Won Ki |
author2Str |
Lee, Jeeyun Yi, Chin-A Park, Se Hoon Park, Joon Oh Park, Young Suk Lim, Ho Yeong Park, Keon Woo Kang, Won Ki |
ppnlink |
SPR009286586 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1007/s10120-011-0104-7 |
up_date |
2024-07-04T01:35:17.262Z |
_version_ |
1803610402078064640 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR009317791</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20201124064103.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201005s2011 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s10120-011-0104-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR009317791</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s10120-011-0104-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kong, Jee Hyun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background There are only limited data regarding pulmonary metastasis from gastric cancer. Therefore, we analyzed large series of gastric cancer with pulmonary metastasis and analyzed their clinical characteristics and treatment outcome to enhance perception of metastatic gastric cancer. Methods Of 20,187 advanced gastric cancer patients treated between 1995 and 2007, 193 (0.96%) were identified to have pulmonary metastasis from gastric cancer. The pulmonary lesions were detected at chest computed tomography (CT) scan or plain chest X-ray and/or abdominal pelvic CT scan covering the lower part of the lungs, and were divided into three patterns: lymphangitic, hematogenous, and pleural. Results The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%). Patients who had hematogenous pulmonary metastasis were significantly associated with hepatic metastasis (p = 0.004) and male sex (p = 0.012). Patients with lymphangitic metastasis were significantly associated with concomitant bone (p = 0.010) and bone marrow (p = 0.029) metastasis. In case of pleural metastasis, it was positively correlated with gastrectomy history (p = 0.015) and the presence of peritoneal metastasis (p = 0.020). After a median follow-up duration of 87 (9–162) months, the median survival after diagnosis of pulmonary metastasis was 4 (0–67) months. Conclusion The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pulmonary metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastric cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematogenous metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphangitic metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pleural metastasis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Jeeyun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yi, Chin-A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Se Hoon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Joon Oh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Young Suk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lim, Ho Yeong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Keon Woo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, Won Ki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Gastric Cancer</subfield><subfield code="d">Springer-Verlag, 2002</subfield><subfield code="g">15(2011), 3 vom: 29. Okt., Seite 292-298</subfield><subfield code="w">(DE-627)SPR009286586</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:3</subfield><subfield code="g">day:29</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:292-298</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s10120-011-0104-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2011</subfield><subfield code="e">3</subfield><subfield code="b">29</subfield><subfield code="c">10</subfield><subfield code="h">292-298</subfield></datafield></record></collection>
|
score |
7.3996496 |